Canagliflozin -- Benefit Assessment According to §35a Social Code Book V [Internet].

The aim of this report was to assess the added benefit of canagliflozin for the treatment of adult patients with type 2 diabetes mellitus in comparison with the appropriate comparator therapy (ACT) in the following approved subindications:

http://ift.tt/2sen02c

http://ift.tt/2rzEcgz